Table 1. Patient characteristics at baseline.
| Characteristic | n (%) |
|---|---|
| Patients enrolled | 41 |
| Age (years) | |
| Median | 61 |
| Range | 25–80 |
| Sex | |
| Male | 23 (56) |
| Female | 18 (44) |
| Karnofsky PS | |
| 70–80 | 16 (39) |
| 90–100 | 25 (61) |
| Site of metastases | |
| Liver | 33 (80) |
| Lymphnodes | 8 (20) |
| Lung | 12 (29) |
| Peritoneum | 5 (12) |
| Number of metastatic lesions | |
| 1 | 1 (2) |
| 2–5 | 24 (59) |
| >5 | 16 (39) |
| Prior therapy | |
| Prior pancreatic surgery | 18 (44) |
| Prior radiotherapy | 14 (34) |
| Prior chemotherapy lines | |
| n=1 | 35 (85)* |
| n>1 | 6 (15) |
| *Gemcitabine alone | 17 (49) |
| *Combination | 18 (51) |
PS=performance status; n=number.
*
In all, 35 patients received 1 prior chemotheraphy line. Of those, 17 received Gemcitabine alone and 18 received a combination chemotherapy.